NNM Securities

ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE1094.0031.3 (+2.95 %)

PREV CLOSE ( ) 1062.70

OPEN PRICE ( ) 1076.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3421

TODAY'S LOW / HIGH ( )1064.20 1101.60

52 WK LOW / HIGH ( )385.05 1358.8

NSE1092.4027.4 (+2.57 %)

PREV CLOSE( ) 1065.00

OPEN PRICE ( ) 1074.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1092.40 (155)

VOLUME 52477

TODAY'S LOW / HIGH( ) 1068.05 1101.95

52 WK LOW / HIGH ( )380.1 1359.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-07 1992

Management Info

Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director

Registered Office

Address Orchid Towers,313 , Valluvar Kottam High Road,Nungambakkam,
Chennai,
Tamil Nadu-600034

Phone 044-28211000

Email corporate@orchidpharma.com / nikitak@orchidpharma.com

Website www.orchidpharma.com

Registrars Details

Abhipra Capital Ltd

Abhipra Complex,A-387 Azadpur,Dilkush Indl.Area G T Karnal Road ,New Delhi

Listing : BSE, NSE

NEWS

08Feb Orchid Pharma informs about outcome of
Orchid Pharma has informed that pursuant to Regulation 30 read Schedule..

31Jan Orchid Pharma informs about disclosure
In accordance to regulation 30 read with Part A of Schedule III of Secur..

27Dec Orchid Pharma informs about disclosures
Orchid Pharma has informed that the Exchange has received the disclosure..

26Dec Orchid Pharma informs about disclosure
Orchid Pharma has informed that it enclosed the disclosure under Regulat..

26Dec Orchid Pharma informs about disclosures
Orchid Pharma has informed that it enclosed the disclosure under Regulat..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	305.45	541.89
Gross Profit	305.45	552.47
Operating Profit	433.51	1030.49
Net Sales	2205.91	6658.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE) 6217.15 (4.47%)	M.Cap (Rs. in Cr)103713.42
Abbott India (BSE) 25725.00 (1.03%)	M.Cap (Rs. in Cr)54663.83
Bharat Parenterals (BSE) 1701.80 (10.00%)	M.Cap (Rs. in Cr)990.39
Alkem Laboratories (BSE) 4857.90 (3.10%)	M.Cap (Rs. in Cr)58083.48
NGL Fine-Chem (BSE) 2711.85 (3.47%)	M.Cap (Rs. in Cr)1675.39

Shareholding Pattern

	PROMOTERS	69.84%
	MUTUAL FUNDS/UTI	15.18%
	NON-INSTITUTION	10.47%
	FI/BANKS/INSURANCE	1.05%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Multi Asset Fund(G)	7.21
Quant Value Fund-Reg(G)	5.44
Tata India Pharma &...	2.08
ITI Pharma & Health...	1.73
ITI Value Fund-Reg(G)	1.22
UTI Healthcare Fund...	1.12
Nippon India Pharma...	1.06

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

ORCHID PHARMA LTD.

Filing compliant on SCORES – Easy & quick